Matches in Wikidata for { <http://www.wikidata.org/entity/Q95357301> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q95357301 description "im August 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95357301 description "wetenschappelijk artikel" @default.
- Q95357301 description "наукова стаття, опублікована в серпні 2017" @default.
- Q95357301 name "A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients" @default.
- Q95357301 name "A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients" @default.
- Q95357301 type Item @default.
- Q95357301 label "A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients" @default.
- Q95357301 label "A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients" @default.
- Q95357301 prefLabel "A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients" @default.
- Q95357301 prefLabel "A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients" @default.
- Q95357301 P1433 Q95357301-2F9FD6CC-525D-4571-8555-1E793FF32624 @default.
- Q95357301 P1476 Q95357301-D7D75B60-2A1F-4C9A-82A3-3E60EEEFC069 @default.
- Q95357301 P2093 Q95357301-1DF5894C-5AF1-4573-9905-C42F4E3B11C6 @default.
- Q95357301 P2093 Q95357301-7C495D43-5B32-4643-A909-A471D4B545BF @default.
- Q95357301 P2093 Q95357301-BBD1E5BA-B973-4C33-B94F-F26061B99DEC @default.
- Q95357301 P2093 Q95357301-BED51463-2023-481C-B91F-B6E383BAAFA7 @default.
- Q95357301 P2093 Q95357301-CE86B564-DB2C-4D3D-9A5A-0A886786F266 @default.
- Q95357301 P2093 Q95357301-E55683F6-6804-486D-8644-D00912E688CB @default.
- Q95357301 P304 Q95357301-ADF80315-B26F-401D-8EB0-9C033C0A4EE1 @default.
- Q95357301 P31 Q95357301-9A4DBA0D-AC25-4B47-81EF-E817E06ACA97 @default.
- Q95357301 P356 Q95357301-39E6D056-E51E-44C2-853E-D862BB94F03C @default.
- Q95357301 P433 Q95357301-BAB4DCAF-D92F-4E91-8CDA-443DB3EBEF4D @default.
- Q95357301 P478 Q95357301-71AD7FF7-483A-4620-8010-54BCC2E0F6A1 @default.
- Q95357301 P50 Q95357301-A6AAF519-5BC6-4C48-81B7-9F5BDB1E6F4B @default.
- Q95357301 P577 Q95357301-3FA25E7E-02C4-47E6-A631-13F10ECE12EE @default.
- Q95357301 P698 Q95357301-131178C4-9F7F-4F94-B643-55A5EA07E07B @default.
- Q95357301 P921 Q95357301-DD987A7C-EADC-4D12-B8AA-915860BEEF4D @default.
- Q95357301 P356 CN108974 @default.
- Q95357301 P698 28671062 @default.
- Q95357301 P1433 Q15763520 @default.
- Q95357301 P1476 "A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients" @default.
- Q95357301 P2093 "Akifumi Fujii" @default.
- Q95357301 P2093 "Keitaro Yokoyama" @default.
- Q95357301 P2093 "Motoi Odani" @default.
- Q95357301 P2093 "Tadao Akizawa" @default.
- Q95357301 P2093 "Takashi Akiba" @default.
- Q95357301 P2093 "Takashi Shigematsu" @default.
- Q95357301 P304 "68-78" @default.
- Q95357301 P31 Q13442814 @default.
- Q95357301 P356 "10.5414/CN108974" @default.
- Q95357301 P433 "2" @default.
- Q95357301 P478 "88" @default.
- Q95357301 P50 Q56997226 @default.
- Q95357301 P577 "2017-08-01T00:00:00Z" @default.
- Q95357301 P698 "28671062" @default.
- Q95357301 P921 Q3622611 @default.